Before we get into the company's narrative, take a look at the base that has built out. There is an incredibly strong "point of control" that has been building for three years.

A lift from this gets the prior pump levels in play up at $15.

It's a straightforward POC breakout, but there are some very cool stories that the company could latch onto as we move into the "applied AI" theme in the markets.

Recursion Pharma is a biotech platform play. That means instead of focusing on an individual drug, they have a proprietary software platform that helps them do drug discovery.

It's Pharma AI.

Here's a link to their recent presentation

Here is their pipeline:

Note that there are a few FDA catalysts that are up on deck for the next few months.

Here's some other considerations about the company:

using a software platform to develop drugs drastically reduces the time and cost of getting new drugs into an FDA pipeline. Not only does this give investors faster upside, it means they can continue to secure funding to help test these new drugs.
Last year they created BioHive-2, the largest supercomputer in the pharma space
AI discovered drugs are going to come out of left field with respect to our expected knowledge. It's like comparing early prototypes of air flight vs a learjet now
The platform may be more valuable than the drugs themselves, making them a viable buyout target

Plenty of narrative tailwinds can help this stock finally get liftoff.

The stock has had a tough time holding above $8:

This is an hourly chart of the stock. Every attempt to push above $8 (and the 200 EMA) has been met with sellers, but the bid continues to march higher, forming higher lows. If marginal sellers clear out and the stock pops and holds $8, you'll see momentum chasers light this on fire and get a solid rally for the stock.

The Most Valuable Part of This Report Is Just Ahead

To continue reading this premium analysis, unlock full access below.

Upgrade

Upgrade now and get the full article along with these benefits:

Trade Setups That Work Risk-defined strategies built on insider activity, volatility behavior, momentum shifts, and liquidity dynamics.
Macro Intelligence and Sector Rotations Early-stage insights into AI infrastructure, defense cycles, energy trends, and emerging tech opportunities.
Priority Access to Our Best Ideas Deep-dive reports, bonus stock picks, and premium research you will not find in the free feed.

Market Traders Daily

Address:
14422 Shoreside Way Suite 110-160 Winter Garden, FL 34787

Support:
[email protected]
Phone:
+1 (888) 228-2376

Profile

IMPORTANT! BY READING OUR CONTENT YOU EXPLICITLY AGREE TO THE FOLLOWING.

DISCLOSURE: Global Profit Systems International LLC, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above.

The Company is not affiliated with, nor does it receive compensation from, any specific security.

While the Company will not engage in front-running or trading against its own recommendations, The Company and its managers and employees reserve the right to hold possession in certain securities featured in its communications.

The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendations.

ALWAYS DO YOUR OWN RESEARCH and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment. Indemnification/Release of Liability.

By reading this communication, you agree to the terms of this disclaimer, including, but not limited to: releasing The Company, its affiliates, assigns and successors from any and all liability, damages, and injury from the information contained in this communication.

You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.

Forward-Looking Statement. As defined in the United States Securities Act of 1933 Section 27(a), as amended in the Securities Exchange Act of 1934 Section 21(e), statements in this communication which are not purely historical are forward-looking statements and include statements regarding beliefs, plans, intent, predictions or other statements of future tense. Past Performance is Not Indicative of Future Results.

Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security.

Don’t trade with money you can’t afford to lose. This is neither a solicitation nor an offer to Buy/Sell securities. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site.

The past performance of any trading system or methodology is not necessarily indicative of future resultsCFTC RULE 4.41 – HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY.

SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

All trades, patterns, charts, systems, etc., discussed in this message and the product materials are for illustrative purposes only and not to be construed as specific advisory recommendations.

All ideas and material presented are entirely those of the author and do not necessarily reflect those of the publisher.

No system or methodology has ever been developed that can guarantee profits or ensure freedom from losses. No representation or implication is being made that using the methodology or system will generate profits or ensure freedom from losses.

The testimonials and examples used herein are exceptional results, which do not apply to the average member and are not intended to represent or guarantee that anyone will achieve the same or similar results.

This material is not an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only.

Any performance results discussed herein represent past performance, not a guarantee of future performance, and are not indicative of any specific investment. Due to the timing of the information presented, investment performance may be adjusted after the publication of this report. There can be no assurance that the future performance of any specific investment, investment strategy, or product made reference to directly or indirectly in this communication will be profitable, equal any corresponding indicated historical performance levels or be suitable for your portfolio.

All data in this communication is provided for informational purposes only and is not intended for trading or investing purposes. We expressly disclaim the accuracy, adequacy, or completeness of any data and content provided by financial exchanges, individual issuers, their respective affiliates, and business partners and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon. You agree not to copy, modify, reformat, download, store, reproduce, reprocess, transmit or redistribute any data or information found herein or use any such data or information in a commercial enterprise without obtaining our prior written consent.

We make no express or implied warranties or representations and shall have no liability whatsoever with respect to any data contained herein. The data may not be further redistributed or used to create indices or other financial products. This report and the views expressed herein are subject to change at any time based upon market or other conditions (such as domestic and global economic trends) and are current as of the date of publication hereof. The information, analysis, and opinions expressed herein are for general information only and are not intended to provide specific advice or recommendations for any individual or entity.

We emphasize that Investment in the securities of smaller companies can involve greater risk than is generally associated with an investment in larger, more established companies, and can result in significant capital losses that may have a detrimental effect on the value of your investments.

Forecasting represents predictions of market prices and/or volume patterns utilizing varying analytical data. It is not representative of a projection of the stock market, or of any specific investment.Nothing contained in this material is intended to constitute legal, tax, securities or investment advice, nor an opinion regarding the appropriateness of any investment. The general information contained in this publication should not be acted upon without obtaining specific legal, tax and investment advice from a licensed professional.
Please remember that all investments carry some level of risk, including the potential loss of principal invested. They do not typically grow at an even rate of return and may experience negative growth. As with any structuring of a portfolio of investments, attempting to reduce risk and increase return could, at certain times, unintentionally reduce returns.

The information, analysis, and opinions expressed herein are for general, impersonal information only and are not intended to provide specific advice or recommendations for any individual entity.

Report abuse

Another Biotech Platform Play For Us - Recursion Pharma

The Most Valuable Part of This Report Is Just Ahead

Upgrade now and get the full article along with these benefits:

Keep Reading

Market Traders Daily

Market Traders Daily